Efficacy and safety comparing prasugrel/ticagrelor and clopidogrel in Hong Kong post‐acute coronary syndrome patients–A 10‐year cohort study

Background Clinical evidence of prasugrel/ticagrelor in dual antiplatelet therapy (DAPT) in Asian acute coronary syndrome (ACS) population remains inconclusive. We aimed to compare the clinical efficacy and safety of prasugrel/ticagrelor compared to clopidogrel as part of DAPT in Hong Kong ACS popul...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Clinical cardiology (Mahwah, N.J.) N.J.), 2021-08, Vol.44 (8), p.1072-1079
Hauptverfasser:	Lam, Amy S. M., Yan, Bryan P. Y., Lee, Vivian W. Y.
Format:	Artikel
Sprache:	eng
Schlagworte:	acute coronary syndrome Acute Coronary Syndrome - diagnosis Acute Coronary Syndrome - drug therapy Acute coronary syndromes Aggregation Anemia Angioplasty Anticoagulants Anticoagulants (Medicine) Blood platelets Cardiac arrhythmia Cardiac patients Cardiovascular disease Censorship Clinical Investigations Clopidogrel - adverse effects Cohort analysis Cohort Studies Comparative analysis Coronary vessels Dabigatran etexilate Diabetes dual antiplatelet therapy efficacy Glycoproteins Heart attack Heart attacks Heart failure Histamine Hong Kong - epidemiology Hospitalization Humans Hypertension Kidney diseases Liver diseases Medical research Medicine, Experimental P2Y12 inhibitor Pantoprazole Patients Percutaneous Coronary Intervention Platelet Aggregation Inhibitors - adverse effects Population Prasugrel Hydrochloride - adverse effects Purinergic P2Y Receptor Antagonists Retrospective Studies safety Sensitivity analysis Stroke Ticagrelor Treatment Outcome Variables
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!